• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

耐药病原体传播模型。

Models for the spread of resistant pathogens.

作者信息

Levin B R

机构信息

Emory University, Department of Biology, Atlanta, GA 30322, USA.

出版信息

Neth J Med. 2002 Aug;60(7 Suppl):58-64; discussion 64-6.

PMID:12430592
Abstract

I consider three mathematical models of the epidemiology of antibiotic treatment and the evolution of resistance. All of these models explore the relationship between the volume of antibiotic use and the frequency and rate of ascent (or descent) of resistance. The first model is in the population genetics tradition and assumes that in the absence of treatment the frequency of resistance wanes at a rate proportional to the fitness costs associated with resistance, but precipitously ascends to high frequencies in treated patients. The second two models are in the compartment, or SIR, model tradition of infectious disease epidemiology. The first of these considers the relationship between resistance and rates of antibiotic treatment in open communities. The second explores the factors contributing to the frequency of resistance in the closed settings of hospitals and nursing homes. While I give some consideration to the epidemiological and medical implications of the results of the analysis of the properties of these models, for the most part the models are the message. I end with a harangue about the utility of simple mathematics for these considerations and a plea to obtain realistic estimates of the parameters of these models and test the validity of the predictions generated from the analysis of these models.

摘要

我考虑了抗生素治疗流行病学和耐药性演变的三种数学模型。所有这些模型都探讨了抗生素使用量与耐药性上升(或下降)的频率和速率之间的关系。第一个模型遵循群体遗传学传统,假设在不进行治疗的情况下,耐药性频率以与耐药相关的适应度成本成比例的速率下降,但在接受治疗的患者中会急剧上升至高频。后两个模型遵循传染病流行病学的 compartment 模型或 SIR 模型传统。其中第一个考虑了开放社区中耐药性与抗生素治疗速率之间的关系。第二个探讨了导致医院和疗养院等封闭环境中耐药性频率的因素。虽然我对这些模型特性分析结果的流行病学和医学意义进行了一些思考,但在很大程度上,模型本身就是关键所在。我最后慷慨陈词,强调简单数学对于这些思考的实用性,并呼吁获取这些模型参数的现实估计值,并检验从这些模型分析中得出的预测的有效性。

相似文献

1
Models for the spread of resistant pathogens.耐药病原体传播模型。
Neth J Med. 2002 Aug;60(7 Suppl):58-64; discussion 64-6.
2
Minimizing potential resistance: a population dynamics view.最小化潜在抗性:种群动态视角
Clin Infect Dis. 2001 Sep 15;33 Suppl 3:S161-9. doi: 10.1086/321843.
3
Antibiotic resistance: location, location, location.抗生素耐药性:位置,位置,还是位置。
Clin Microbiol Infect. 2007 Jun;13 Suppl 2:7-16. doi: 10.1111/j.1469-0691.2007.01724.x.
4
[The effect of antimicrobial use on emergence and selection of resistance].抗菌药物使用对耐药性产生及选择的影响
Anasthesiol Intensivmed Notfallmed Schmerzther. 2007 Feb;42(2):130-5. doi: 10.1055/s-2007-971165.
5
[Antibiotic resistance--bacteria fight back].[抗生素耐药性——细菌的反击]
Acta Med Croatica. 2004;58(4):245-50.
6
Drug resistance models for malaria.疟疾的耐药模型
Acta Trop. 2005 Jun;94(3):207-17. doi: 10.1016/j.actatropica.2005.04.006.
7
At the threshold: defining clinically meaningful resistance thresholds for antibiotic choice in community-acquired pneumonia.在阈值处:确定社区获得性肺炎抗生素选择的临床意义上的耐药阈值
Clin Infect Dis. 2008 Apr 15;46(8):1131-8. doi: 10.1086/529440.
8
Effect of an intensive care unit rotating empiric antibiotic schedule on the development of hospital-acquired infections on the non-intensive care unit ward.重症监护病房经验性抗生素轮换方案对非重症监护病房医院获得性感染发生情况的影响
Crit Care Med. 2004 Jan;32(1):53-60. doi: 10.1097/01.CCM.0000104463.55423.EF.
9
Healthcare-associated bloodstream infection: A distinct entity? Insights from a large U.S. database.医疗保健相关血流感染:一种独特的实体?来自美国大型数据库的见解。
Crit Care Med. 2006 Oct;34(10):2588-95. doi: 10.1097/01.CCM.0000239121.09533.09.
10
Effects of duplicate and screening isolates on surveillance of community and hospital antibiotic resistance.重复分离株和筛查分离株对社区及医院抗生素耐药性监测的影响。
J Antimicrob Chemother. 2004 Jul;54(1):155-62. doi: 10.1093/jac/dkh295. Epub 2004 Jun 9.

引用本文的文献

1
β-Lactam-Resistant Streptococcus pneumoniae Dynamics Following Treatment: A Dose-Response Meta-analysis.β-内酰胺类耐药肺炎链球菌治疗后的动态变化:剂量反应荟萃分析。
Clin Infect Dis. 2022 Nov 30;75(11):1962-1970. doi: 10.1093/cid/ciac293.
2
Salicylate Increases Fitness Cost Associated with MarA-Mediated Antibiotic Resistance.水杨酸盐增加了 MarA 介导的抗生素耐药性相关的适应代价。
Biophys J. 2019 Aug 6;117(3):563-571. doi: 10.1016/j.bpj.2019.07.005. Epub 2019 Jul 10.
3
Drug repositioning, a new alternative in infectious diseases.药物重新定位,传染病领域的一种新选择。
Braz J Infect Dis. 2018 May-Jun;22(3):252-256. doi: 10.1016/j.bjid.2018.05.007. Epub 2018 Jun 28.
4
Drug repurposing screens and synergistic drug-combinations for infectious diseases.药物重定位筛选和传染病协同药物组合。
Br J Pharmacol. 2018 Jan;175(2):181-191. doi: 10.1111/bph.13895. Epub 2017 Jul 9.
5
The skill and style to model the evolution of resistance to pesticides and drugs.模拟对杀虫剂和药物抗性演变的技巧与风格。
Evol Appl. 2010 Jul;3(4):375-90. doi: 10.1111/j.1752-4571.2010.00124.x. Epub 2010 Mar 29.
6
Childhood pneumonia in developing countries.发展中国家的儿童肺炎。
Lancet Respir Med. 2013 Sep;1(7):574-84. doi: 10.1016/S2213-2600(13)70075-4. Epub 2013 Jun 18.
7
Risk factors for multidrug-resistant invasive pneumococcal disease in South Africa, a setting with high HIV prevalence, in the prevaccine era from 2003 to 2008.南非高艾滋病毒流行地区,疫苗时代前(2003 年至 2008 年),耐多药侵袭性肺炎球菌病的危险因素。
Antimicrob Agents Chemother. 2012 Oct;56(10):5088-95. doi: 10.1128/AAC.06463-11. Epub 2012 Jul 16.
8
Probability of emergence of antimalarial resistance in different stages of the parasite life cycle.疟原虫生命周期不同阶段出现抗疟药耐药性的概率。
Evol Appl. 2009 Feb;2(1):52-61. doi: 10.1111/j.1752-4571.2008.00067.x.
9
Antibiotic resistance and its cost: is it possible to reverse resistance?抗生素耐药性及其代价:逆转耐药性是否可行?
Nat Rev Microbiol. 2010 Apr;8(4):260-71. doi: 10.1038/nrmicro2319. Epub 2010 Mar 8.
10
Translational systems approaches to the biology of inflammation and healing.炎症和愈合生物学的转化系统方法。
Immunopharmacol Immunotoxicol. 2010 Jun;32(2):181-95. doi: 10.3109/08923970903369867.